Advertisement
Canada markets open in 3 hours 34 minutes

  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CAD/USD

    0.7309
    -0.0012 (-0.16%)
     

  • CRUDE OIL

    83.00
    -0.36 (-0.43%)
     

  • Bitcoin CAD

    90,782.86
    +363.43 (+0.40%)
     

  • CMC Crypto 200

    1,432.35
    +8.25 (+0.58%)
     

  • GOLD FUTURES

    2,328.50
    -13.60 (-0.58%)
     

  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     

  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     

  • NASDAQ futures

    17,682.50
    +75.75 (+0.43%)
     

  • VOLATILITY

    15.85
    +0.16 (+1.02%)
     

  • FTSE

    8,083.55
    +38.74 (+0.48%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6837
    +0.0001 (+0.01%)
     

Could This Drug Class Change Medicine As We Know It?

The Motley Fool Videos
Updated

Healthcare analyst Max Macaluso thinks understanding RNAi drugs is as easy as picturing leaky faucet. In this case, you can either put a bucket down to catch the drip, or you can simply turn off the faucet. Drugs out on the market now are like the buckets, but RNAi would be turning the faucet off altogether. Learn more about this revolutionary treatment method and the one company working in the space that looks the most promising in this clip of Industry Focus: Healthcare.

This podcast was recorded on Mar. 10, 2016.